@EU_Startups
NOVADIP Biosciences, a #Belgian late-stage clinical #BioTech company specialising in #regenerative #medicine, has closed a €10.4 million convertible #financing round. 🇧🇪 🧬 🦴

https://t.co/v0coHkOc2D https://t.co/JKnKw1cCNd
Post image
4
You’ve reached the end 🎉

Cookies allow you to use this website normally and customize your experience on this website.

>>More information